AngioDynamics, Inc. Forecast, price target & analysts
AngioDynamics, Inc. Target price 2026 - Analyst rating & recommendation
AngioDynamics, Inc. Classifications & Recommendation
AngioDynamics, Inc. Price Target
| Target Price | $19.89 |
| Price | $15.46 |
| Potential |
28.65%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target AngioDynamics, Inc. 2027 .
The average AngioDynamics, Inc. target price is $19.89.
This is
28.65%
register free of charge
$25.20
63.00%
register free of charge
$17.17
11.06%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend AngioDynamics, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AngioDynamics, Inc. stock has an average upside potential 2027 of
28.65%
register free of charge
|
Sales and Margin forecast 2027, 2028 to 2031
| May '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million $ | 320.17 | 344.15 |
| 9.46% | 7.49% | |
| EBITDA Margin | -3.64% | 4.08% |
| 24.09% | 212.13% | |
| Net Margin | -11.48% | -3.30% |
| 1.25% | 71.24% |
6 Analysts have issued a sales forecast AngioDynamics, Inc. 2027 . The average AngioDynamics, Inc. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an AngioDynamics, Inc. EBITDA forecast 2027. The average AngioDynamics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 AngioDynamics, Inc. Analysts have issued a net profit forecast 2027. The average AngioDynamics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031
| May '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.88 | -0.27 |
| 6.02% | 69.32% | |
| P/E | negative | |
| EV/Sales | 1.72 |
6 Analysts have issued a AngioDynamics, Inc. forecast for earnings per share. The average AngioDynamics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
AngioDynamics, Inc....
Current AngioDynamics, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jul 15 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 15 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Apr 06 2026 |
| Freedom Broker |
Locked
➜
Locked
|
Locked | Apr 06 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Oct 03 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jul 15 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 15 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Apr 06 2026 |
|
Locked
Freedom Broker:
Locked
➜
Locked
|
Apr 06 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Oct 03 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 16 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
